Determinants of carriage of resistant Escherichia coli in the Indonesian population inside and outside hospitals

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 2, 2007, Pages 377-384

  Duerink, Offra D ^a   Lestari, Endang S ^b   Hadi, Usman ^c   Nagelkerke, Nico J D ^d   Severin, Juliëtte A ^e   Verbrugh, Henri A ^e   Keuter, Monique ^f   Gyssens, Inge C ^e   van den Broek, Peterhans J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DIPONEGORO UNIVERSITY   (Indonesia)

^c AIRLANGGA UNIVERSITY   (Indonesia)

^d UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibacterial agents; Drug resistance; Risk factors

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIINFECTIVE AGENT; CARBAPENEM; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MACROLIDE; METRONIDAZOLE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATE; COMMUNITY CARE; CONFIDENCE INTERVAL; DIARRHEA; DISEASE TRANSMISSION; DRUG USE; ESCHERICHIA COLI; FEMALE; HEALTH INSURANCE; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INDONESIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIMARY HEALTH CARE; SOCIOECONOMICS; SYMPTOMATOLOGY;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS INFECTION; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALIZATION; HUMANS; INDONESIA; MICROBIAL SENSITIVITY TESTS; ODDS RATIO; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 34547828219     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm197     Document Type: Article

References (32)

1. Shears P. Antibiotic resistance in the tropics. Epidemiology and surveillance of antimicrobial resistance in the tropics. Trans R Soc Trop Med Hyg 2001; 95: 127-30.
2. Okeke IN, Klugman KP, Bhutta ZA et al. Antimicrobial resistance in developing countries. Part II: Strategies for containment. Lancet Infect Dis 2005; 5: 568-80.
3. McDonald LC, Chen FJ, Lo HJ et al. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother 2001; 45: 3084-91.
4. Bell JM, Tumidge JD, Jones RN. Prevalence of extended-spectrum β-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001. Antimicrob Agents Chemother 2003; 47: 3989-93.
5. Chong Y, Lee K, Park YJ et al. Korean Nationwide Surveillance of Antimicrobial Resistance of bacteria in 1997. Yonsei Med J 1998; 39: 569-77.
6. Goldmann DA, Huskins WC. Control of nosocomial antmicrobial-resistant bacteria: A strategic priority for hospitals worldwide. Clin Infect Dis 1997; 24 Suppl 1: S139-45.
7. Hsueh PR, Liu CY, Luh KT. Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis 2002; 8: 132-7.
8. Hsueh PR, Chen ML, Sun CC et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg Infect Dis 2002; 8: 63-8.
9. Kim WJ, Park SC. Bacterial resistance to antimicrobial agents: An overview from Korea. Yonsei Med J 1998; 39: 488-94.
10. Oyofo BA, Lesmana M, Subekti D et al. Surveillance of bacterial pathogens of diarrhea disease in Indonesia. Diagn Microbiol Infect Dis 2002; 44: 227-34.
11. Kuntaman K, Lestari ES, Severin JA et al. Fluoroquinolone-resistant Escherichia coli Indonesia. Emerg Infect Dis 2005; 11: 1363-9.
12. Subekti DS, Lesmana M, Tjaniadi P et al. Prevalence of enterotoxigenic Escherichia coli (ETEC) in hospitalized acute diarrhea patients in Denpasar, Bali, Indonesia. Diagn Microbiol Infect Dis 2003; 47: 399-405.
13. Tjaniadi P, Lesmana M, Subekti D et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg 2003; 68: 666-70.
14. Sheng WH, Chen YC, Wang JT et al. Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan. Diagn Microbiol Infect Dis 2002; 43: 141-7.
15. Lewis MT, Biedenbach DJ, Jones RN. In vitro evaluation of cefepime and other broad-spectrum β-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 1999; 35: 285-90.
16. Agtini MD, Soehamo R, Lesmana M et al. The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: Findings from 24 months surveillance. BMC Infect Dis 2005; 5: 89.
17. Lesmana M, Subekti DS, Tjaniadi P et al. Spectrum of vibrio species associated with acute diarrhea in North Jakarta, Indonesia. Diagn Microbiol Infect Dis 2002; 43: 91-7.
18. Lesmana M, Subekti D, Simanjuntak CH et al. Vibrio parahaemolyticus associated with cholera-like diarrhea among patients in North Jakarta, Indonesia. Diagn Microbiol Infect Dis 2001; 39: 71-5.
19. Donegan EA, Wirawan DN, Muliawan P et al. Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004. Sex Transm Dis 2006; 33: 625-9.
20. Bronzwaer SL, Cars O, Buchholz U et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002; 8: 278-82.
21. Farra A, Skoog G, Wallen L et al. Antibiotic use and Escherichia coli resistance trends for quinolones and cotrimoxazole in Sweden. Scand J Infect Dis 2002; 34: 449-55.
22. Harbarth S, Samore MH. Antimicrobial resistance determinants and future control. Emerg Infect Dis 2005; 11: 794-801.
23. Jansson C, Franklin A, Skold O. Trimethoprim resistance arising in animal bacteria and transferring into human pathogens. J Infect Dis 1993; 167: 785-7.
24. Levy SB, FitzGerald GB, Macone AB. Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. N Engl J Med 1976; 296: 583-8.
25. Bruinsma N, Stobberingh E, de Smet P et al. Antibiotic use and the prevalence of antibiotic resistance in bacteria from healthy volunteers in the Dutch community. Infection 2003; 31: 9-14.
26. WHO Collaborating Centre for Drug Statistics Methodology 2003. Anatomic Therapeutical Chemical (ATC) classification index with Defined Daily Doses (DDDs). http://www.whocc.no/atcddd (11 October 2006, date last accessed).
27. BPS-Statistics Indonesia BAPPENAS, UNDP. Indonesia Human Development Report 2004 The Economics of Democracy Financing human development in Indonesia, 2004.
28. Filius PM, van Netten D, Roovers PJ et al. Comparative evaluation of three chromogenic agars for detection and rapid identification of aerobic Gram-negative bacteria in the normal intestinal microflora. Clin Microbiol Infect 2003; 9: 912-8.
29. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disc Susceptibility: Approved Standard M2-A7 NCCLS, Villanova, PA, USA, 2000.
30. Okeke IN, Laxminarayan R, Bhutta ZA et al. Antimicrobial resistance in developing countries. Part I: Recent trends and current status. Lancet Infect Dis 2005; 5: 481-93.
31. Tenover FC, Hughes JM. The challenges of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens. JAMA 1996; 275: 300-4.
32. Tenover FC, McGowan JE Jr. Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996; 311: 9-16.